OccuLogix, Inc.

OccuLogix, Inc.

November 09, 2005 08:51 ET

OccuLogix Achieves ISO 13485:2003 Certification

TORONTO, ONTARIO--(CCNMatthews - Nov. 9, 2005) - OccuLogix, Inc. (NASDAQ:RHEO)(TSX:RHE) today announced that it has received company-wide certification to ISO 13485:2003. ISO 13485:2003 is the certification standard specifically for the medical device industry. Achievement of ISO certification marks a corporate commitment to quality in the design and manufacture of medical devices that spans all levels in an organization.

ISO, the International Organization for Standardization, is a worldwide federation of national standards bodies created to set standards for similar technologies in different countries. Details about ISO and its standards can be found at http://www.iso.org. The ISO 13485:2003 standard specifically focuses on the unique and rigorous requirements for companies involved in the development of medical devices. Achievement of ISO 13485:2003 demonstrates OccuLogix's dedication to continuously improve product quality and reliability; monitor health, safety and environmental protection; provide greater compatibility and interoperability of goods and services; and maximize distribution efficiency.

"This certification is a significant achievement for OccuLogix and demonstrates our on-going commitment to providing the highest quality products and services to our customers. Meeting the ISO standards, which require continuous company oversight, attests to the integrity of our processes and will strengthen our position worldwide," commented Elias Vamvakas, OccuLogix's Chairman and CEO.

About OccuLogix, Inc.

OccuLogix is a health care company that brings innovative and evidenced-based medical therapies to market. OccuLogix's common shares trade on the NASDAQ National Market under the symbol 'RHEO' and on the Toronto Stock Exchange under the symbol 'RHE'. Visit us on the internet at www.occulogix.com (corporate) and www.rheo.com (healthcare professionals, patients and caregivers).

Forward-Looking Statements

This press release may contain forward-looking statements. These statements relate to future events and are subject to risks, uncertainties and assumptions about the company. These statements are only predictions based on our current expectations and projections about future events. You should not place undue reliance on these statements. Actual events or results may differ materially. Many factors may cause our actual results to differ materially from any forward-looking statement, including the factors detailed in our filings with the Securities and Exchange Commission and Canadian regulatory authorities, including our Registration Statement on Form S-1. We do not undertake to update any forward-looking statements.

Contact Information